Literature DB >> 18455326

Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy.

David Palma1, Emily Vollans, Kerry James, Sandy Nakano, Vitali Moiseenko, Richard Shaffer, Michael McKenzie, James Morris, Karl Otto.   

Abstract

PURPOSE: Volumetric modulated arc therapy (VMAT) is a novel form of intensity-modulated radiotherapy (IMRT) optimization that allows the radiation dose to be delivered in a single gantry rotation of up to 360 degrees , using either a constant dose rate (cdr-VMAT) or variable dose rate (vdr-VMAT) during rotation. The goal of this study was to compare VMAT prostate RT plans with three-dimensional conformal RT (3D-CRT) and IMRT plans. PATIENTS AND METHODS: The 3D-CRT, five-field IMRT, cdr-VMAT, and vdr-VMAT RT plans were created for 10 computed tomography data sets from patients undergoing RT for prostate cancer. The parameters evaluated included the doses to organs at risk, equivalent uniform doses, dose homogeneity and conformality, and monitor units required for delivery of a 2-Gy fraction.
RESULTS: The IMRT and both VMAT techniques resulted in lower doses to normal critical structures than 3D-CRT plans for nearly all dosimetric endpoints analyzed. The lowest doses to organs at risk and most favorable equivalent uniform doses were achieved with vdr-VMAT, which was significantly better than IMRT for the rectal and femoral head dosimetric endpoints (p < 0.05) and significantly better than cdr-VMAT for most bladder and rectal endpoints (p < 0.05). The vdr-VMAT and cdr-VMAT plans required fewer monitor units than did the IMRT plans (relative reduction of 42% and 38%, respectively; p = 0.005) but more than for the 3D-CRT plans (p = 0.005).
CONCLUSION: The IMRT and VMAT techniques achieved highly conformal treatment plans. The vdr-VMAT technique resulted in more favorable dose distributions than the IMRT or cdr-VMAT techniques, and reduced the monitor units required compared with IMRT.

Entities:  

Mesh:

Year:  2008        PMID: 18455326     DOI: 10.1016/j.ijrobp.2008.02.047

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  156 in total

1.  Comparative analysis of SmartArc-based dual arc volumetric-modulated arc radiotherapy (VMAT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma.

Authors:  Tsair-Fwu Lee; Pei-Ju Chao; Hui-Min Ting; Su-Hua Lo; Yu-Wen Wang; Chiu-Ching Tuan; Fu-Min Fang; Te-Jen Su
Journal:  J Appl Clin Med Phys       Date:  2011-11-15       Impact factor: 2.102

Review 2.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

3.  RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.

Authors:  J M Park; K Kim; E K Chie; C H Choi; S J Ye; S W Ha
Journal:  Br J Radiol       Date:  2012-07       Impact factor: 3.039

Review 4.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

5.  Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.

Authors:  J G Baek; E C Kim; S K Kim; H Jang
Journal:  Br J Radiol       Date:  2015-09-23       Impact factor: 3.039

6.  A dosimetric comparison of RapidArc and IMRT with hypofractionated simultaneous integrated boost to the prostate for treatment of prostate cancer.

Authors:  K Ishii; R Ogino; W Okada; R Nakahara; R Kawamorita; T Nakajima
Journal:  Br J Radiol       Date:  2013-08-30       Impact factor: 3.039

7.  Toxicity outcome in patients treated with modulated arc radiotherapy for localized prostate cancer.

Authors:  Rafael E Lengua; Maria F Gonzalez; Kaory Barahona; Milton E Ixquiac; Juan F Lucero; Erick Montenegro; Jose L Lopez Guerra; Javier Jaén; Luis A Linares
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-24

8.  A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate Cancer.

Authors:  Maryam Moteabbed; Alexei Trofimov; Gregory C Sharp; Yi Wang; Anthony L Zietman; Jason A Efstathiou; Hsiao-Ming Lu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-12-29       Impact factor: 7.038

9.  Metabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy.

Authors:  J Klein; L A Dawson; T H Tran; O Adeyi; T Purdie; M Sherman; A Brade
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

10.  Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?

Authors:  Enzhuo M Quan; Joe Y Chang; Zhongxing Liao; Tingyi Xia; Zhiyong Yuan; Hui Liu; Xiaoqiang Li; Cody A Wages; Radhe Mohan; Xiaodong Zhang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.